Don't know if your hypothesis is accurate but it sounds logical. MM's can manipulate PPS very well in a stock as thin as this one. Best of luck.
As a long, I'm concerned with today's action but a 3500 share dump in the after hours is hardly a bankruptcy petition. If your going to bash a stock. One which has made you look foolish from the $3's, you should at least not appear brainless to convince any fence sitters.
I hope your correct but honestly, to me it sounds delusional or the musings of a pumper. It's only about 3500 shares but I would feel better if it still isn't taking a beating in the after hours.
Price took off this morning like a bat out of ......... Whatever was the catalyst for the move, (look at the chart!), completely reversed this afternoon. With a vengeance. Inexplicable unless an negative announcement is pending. Hoping today's trading was an overreaction to whatever is coming.
Almost seems to me that someone thought they knew something and took a big position in a hurry, only to realize their mistake and bail later in the day. A disappointment for me. I thought something was up and we were finally going to see the stock price go parabolic based on some major mews. Oh well.
Low float stocks don't need much "swapping" to get some downside action. I'm not saying that SVA is purely an avian flu spec, only that ALL the avian flu stocks got hammered yesterday, other than NVAX. I own it because I feel that the future is as a pharmaceutical manufacturer. But the market, or at least some, might see it differently, hence the price action similar to the bird flu roller coasters. Looking forward to management confirming our feelings on the future of SVA in 11 days. Maybe tomorrow.
I do believe that the NVAX upgrade to $11, (are they insane?!!) moved some money from those that play both SVA and NVAX to NVAX. However observing todays action I'm thinking that since all the avian flu stocks are already down big today, the stocks are down due to the poultry market elimination theory. SVA needs to establish that it's NOT just a speculative bird flu beneficiary. MRK, BMY, SNY etc... don't race up and down on the latest H7N9 news. Time for some news which identifies SVA as a pharmaceutical company and not some manipulated biotech dice throw.
Did everyone swap out of the avian flu players into NVAX? Big upgrade by FBR for NVAX today. SVA, INO and BCRX all down big, even before the afternoon market sell off. I sold my NVAX a month and a half ago. Figured it would skid but has some PR moving it up. We could use some PR or blow out earnings and upwards guidance. Still can't believe that an Asian biotech isn't at the forefront of developing new compounds and monetizing them.
Due for some positive news. It's about time they put up something worth bragging about. You can't tell me that only US biotechs complete successful trials.